PB Ratio of Indo Us Bio-tech Ltd
Indo US Bio-Tech Ltd
NSE: INDOUS
PB Ratio
Key Highlights
- The latest PB Ratio of Indo US Bio-Tech Ltd is 1.6.
- The PB ratio of the Indo US Bio-Tech Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Indo US Bio-Tech Ltd changed from 0.9 on March 2021 to 1.6 on March 2022 . This represents a CAGR of 33.33% over 2 years .
Historical P/B Ratio of Indo US Bio-Tech Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Indo US Bio-Tech Ltd
Company Fundamentals for Indo US Bio-Tech Ltd
Market Cap
150 Cr
EPS
5.7
P/E Ratio (TTM)
13.2
P/B Ratio (TTM)
1.6
Day’s High
79.3
Day’s Low
75.0
DTE
0.4
ROE
14.2
52 Week High
158.85
52 Week Low
72.6
ROCE
12.5
Market Price of Indo US Bio-Tech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 05 Oct 2026 | 75.2 |
| 01 Oct 2026 | 77 |
| 30 Sep 2026 | 77.12 |
| 29 Sep 2026 | 76.32 |
| 28 Sep 2026 | 77.62 |
| 25 Sep 2026 | 80.5 |
| 24 Sep 2026 | 77 |
| 21 Sep 2026 | 77.2 |
| 18 Sep 2026 | 77.06 |
| 17 Sep 2026 | 80.28 |
SWOT Analysis Of Indo US Bio-Tech Ltd
BlinkX Score for Indo US Bio-Tech Ltd
Asset Value vs Market Value of Indo US Bio-Tech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap |
|---|
| Indo US Bio-Tech Ltd | 1.63 | 150.79 |
| Hindustan Unilever Ltd | 209.4 | 432560 |
| ITC Ltd | 58.3 | 322034 |
| Nestle India Ltd | 27.4 | 251414 |
| Varun Beverages Ltd | 57.4 | 143519 |
| Company | |
|---|---|
| Indo US Bio-Tech Ltd | 1.63 |
| Hindustan Unilever Ltd | 209.4 |
| ITC Ltd | 58.3 |
| Nestle India Ltd | 27.4 |
| Varun Beverages Ltd | 57.4 |
PB Ratio of Indo US Bio-Tech Ltd Explained
₹150.79
Market cap
₹46
Book Value per Share
1.6X
PB Ratio
Historical Market Cap of Indo US Bio-Tech Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Indo US Bio-Tech Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Indo US Bio-Tech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Indo US Bio-Tech Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Indo US Bio-Tech Ltd News Hub
Indo US Bio-Tech standalone net profit rises 33.76% in the June 2024 quarter
Net profit of Indo US Bio-Tech rose 33.76% to Rs 3.17 crore in the quarter ended June 2024 as agains
Read more
09 Aug 24
Indo US Bio-Tech to announce Quarterly Result
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 8 August 2024. Powe
Read more
02 Aug 24
Indo US Bio-Tech to conduct AGM
Indo US Bio-Tech announced that the Annual General Meeting (AGM) of the company will be held on 30 S
Read more
18 Sept 24
Indo US Bio-Tech announces board meeting date
Indo US Bio-Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po
Read more
07 Nov 24
